9TH HIV and Women 2019 – Presentations


Day 1 - Saturday, 2 March 2019

 Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy
Chairs: Catherine Hankins and Karoline Aebi-Popp

Gaolathe, Tendani 2019 120x160Clinical case: Researcher perspective

Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana



Clinical case: Community perspective
No slides available
Lucy Wanjiku Njenga - Positive Young Women Voices, Kenya



Clinical case: Policy implications

Meg Doherty, MD, PhD - WHO, UK


 Abstract-driven presentations
Videos are not available for abstract-driven presentations

INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry
Jessica Albano, PhD, MPH - Syneos Health, USA


Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir
Deborah Money, MD - UBC, Canada


Evaluation of neural tube defects after exposure to Raltegravir during pregnancy
Hala Shamsuddin, MD - Merck, USA

 Session 2: New drug delivery systems, are they right for women?
Chair: Sharon Walmsley

Invited lecture, focus on cabotegravir
No slides or video available

Annemiek de Ruiter, MBBS FRCP, MD, ViiV Healthcare, UK


Emerging drug delivery systems for treatment and prevention of HIV

Kimberly Scarsi, PharmD, MS, University of Nebraska, USA


 Abstract-driven presentations
Videos are not available for abstract-driven presentations

Clinical development strategy to inform dosing of antiretroviral drugs in women: dolutegravir as a case study
Kimberly Adkison, PhD - Viiv Healthcare, USA


HIV risk and characteristics of women seeking PrEP in a US demonstration project
Jill Blumenthal, MD - University of California, San Diago, USA

 Session 3: Unique challenges of growing up with HIV
Chairs: Angelina Namiba and Teresia Otieno
 No available presentations due to confidentiality 
 Abstract-driven presentations
Videos are not available for abstract-driven presentations
 High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa
Lynn Matthews, MD - University of Alabama at Birmingham, USA
 Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya
Elizabeth Okoth (presented by N. Rakhmanina), MPH -
Elizabeth Glaser Pediatric AIDS Foundation, Kenya

Day 2 - Sunday, 3 March 2019

 Session 4: Healthy aging with HIV for women
Chair: Margaret Johnson

Bone Health among women aging with HIV

Michael Yin, MD, New York State Psychiatric Institute & Columbia University, USA


 Cardiac Muscle Health Among Women Aging with HIV


Markella Zanni, MD, MGH/Harvard Medical School, USA



Important Drug- Drug interactions in Women aging with HIV

Marta Boffito, MD, PhD, SSAT & Imperial College, Chelsea and Westminster Hospital, UK


 Session 5: Research in women and HIV - 1
Chairs:  Markella Zanni and Patricia Vasquez
Abstract-driven presentations
Note: Videos are not available for abstract-driven presentations

 Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV
Elisabeth McClymont - University of British Columbia, Canada
 Dolutegravir pharmacokinetics during pregnancy and postpartum
Angela Colbers, PhD - Radboud University Medical Center, The Netherlands
 Intimate Partner Violence, Depression, and Mortality among a Cohort
of Women living with HIV Marginalized by Socio-structural Inequities
in Vancouver, Canada
Kalysha Closson - University Of British Columbia, Canada
 Vaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women
Melanie Nicol, PharmD, PhD - University of Minnesota, USA
 Session 6: HIV cure research - considerations for women
Chair: Natella Rakhmanina
 HIV Cure: Where have we been, where are we going?


Daniel Kuritzkes, MD,
Harvard Medical School, USA


Invited lecture:  Focus on women

Jintanat Ananworanich, MD, PhD,

US Military HIV Research Program, USA

 Abstract-driven presentations
Note: Videos are not available for abstract-driven presentations
 Women’s involvement in clinical research: Women included in Dolutegravir clinical trials versus collaborative studies
Romina Quercia, MD, PhD, MPH - ViiV Healthcare, UK